About Alnylam Pharmaceuticals Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.alnylam.com/
Frequently Asked Questions
What is the 52-week range for ALNY?
The 52-week high is $495.55 and the 52-week low is $197.81.
What is the P/E ratio for ALNY?
The Price to Earnings (P/E) ratio is 36.91.
What is the dividend yield for ALNY?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 93.61%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 16.82%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 66.57.
Analyst Recommendation Trends
Wall Street analyst consensus for ALNY over the last few months:
Latest ALNY News
3 Great Healthcare Stocks To Own In October 2026
Global bond markets have just steadied after a sharp sell off that pushed US borrowing costs to levels last seen in 2002, which keeps reliable cash generation and robust finances firmly in focus. That backdrop puts financially solid healthcare leaders, from drug developers to equipment makers, on many watchlists. This article walks through three stand out stocks from a curated healthcare shortlist that meet those quality filters. The three healthcare stocks highlighted next are only a...
Stock Market Today: S&P 500 Slips as Micron Fails to Impress, 10-Year Yields Ease to 5.25%
Micron slides despite a record quarter as the 10-year yield nears 5.3% and oil tops $92, while Accenture, Coherent and Vicor surge on earnings and AI optics.
Here's How Much $100 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth Today
Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 20 years by 5.0% on an annualized basis producing an average annual return of 14.01%. Currently, Alnylam Pharmaceuticals has a market
JP Morgan Maintains Overweight on Alnylam Pharmaceuticals, Lowers Price Target to $369
JP Morgan analyst Jessica Fye maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Overweight and lowers the price target from $375 to $369.
AMVUTTRA® (vutrisiran) ‘Play by Play’ Initiative Highlights Former Athletes’ Stories to Shine a Light on the Often-Missed Signs of ATTR-CM
CAMBRIDGE, Mass., September 29, 2026--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the launch of AMVUTTRA® (vutrisiran) ‘Play by Play,’ a U.S. educational initiative featuring former professional athletes living with the cardiomyopathy of transthyretin-mediated amyloidosis (ATTR-CM) and the care teams who support them. Through personal stories and expert perspectives, ‘Play by Play’ aims to help people recognize the symptoms of ATTR-CM earl
4 RNA Therapeutics Stocks Leading the Next Wave of Innovation
RNA therapeutics are gaining momentum as Alnylam, Ionis, Wave Life Sciences and Arcturus advance innovative treatments targeting a range of diseases.
Alnylam Pharmaceuticals: More Than Meets The Eye After CARDIO-TTRansform
Alnylam Pharmaceuticals, Inc. is down on ATTR-CM fears. TRITON-CM could still succeed, downside is buffered, and shares look undervalued. Click for an ALNY update.
18 of 21 Analysts Still Think Alnylam Stock Is a Buy. Here's Why They're Right.
Wall Street expects an even bigger rebound for this beaten-down biotech stock.
Alnylam Needs Stronger Amvuttra Execution To Justify More Upside
Alnylam at its current ~$255 valuation leaves limited upside without stronger commercial execution, especially for AMVUTTRA. Learn why ALNY stock is a hold.
RNAi drug specialist ADARx raises $446M IPO
ADARx is the only maker of RNA-based drugs to go public since 2024 and the first RNAi biotech to price an IPO in the U.S. in more than a decade.
Novo Nordisk: Capital Markets Day Reveals Its Next Growth Engine
Novo Nordisk A/Sâs 2030 pipeline targets, Wegovy pill growth and Q2 sales show major upside. Click for this NVO stock update.
Was Moderna Stock's Cancer Vaccine Run Visible In Advance?
Moderna (MRNA) stock rose roughly 510% over the year to September 21, 2026, climbing from about $25 to about $173. The S&P 500 gained 18.5% with dividends reinvested over the same window, and Pfizer (PFE) about 23%. The run's central event came on August 19, 2026, when Merck and Moderna said a Phase III trial of their cancer vaccine, intismeran autogene, met its endpoints in melanoma. A rough timetable for the trial was public long before the stock moved, but its result was not.
4 Alzheimer's Drug Stocks to Watch on World Alzheimer's Day
Four biotech stocks advance Alzheimer's therapies, from marketed treatments to experimental programs targeting amyloid and tau.
HC Wainwright & Co. Reiterates Buy on Alnylam Pharmaceuticals, Maintains $455 Price Target
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and maintains $455 price target.
Alnylam Highlights AMVUTTRA Momentum, Resets 2026 TTR Revenue Outlook
Alnylam Pharmaceuticals (NASDAQ:ALNY) highlighted continued momentum for its AMVUTTRA treatment in transthyretin-mediated cardiomyopathy, while outlining a pipeline of upcoming clinical catalysts and discussing changes in the market that prompted a revision to its 2026 TTR franchise revenue outlook.
Alnylam’s Zilebesiran Targets Twice-Yearly Blood Pressure Control in ZENITH Trial
Alnylam Pharmaceuticals (NASDAQ:ALNY) outlined its strategy for advancing zilebesiran, an investigational RNA interference, or RNAi, therapy designed to provide sustained blood-pressure control with twice-yearly dosing for people with uncontrolled hypertension and elevated cardiovascular risk. Duri
RNA Interference Therapeutics Market Outlook 2026-2035 - Featuring Profiles of Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, and Silence Therapeutics
RNAi Therapeutics Expand on Precision Medicine Demand, Advanced Subcutaneous Delivery and Growing Rare Disease ApplicationsDublin, Sept. 18, 2026 (GLOBE NEWSWIRE) -- "RNA Interference Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. Global RNA Interference Therapeutics Market to Reach USD 31.4 Billion by 2035 The global RNA interference therapeutics market was valued at USD 4.2 billion in 2025 a
Alnylam Pharmaceuticals, Inc. (ALNY) Discusses Zilebesiran and the Potential of RNAi Therapeutics for Continuous Blood Pressure Control Transcript
Alnylam Pharmaceuticals, Inc. (ALNY) Discusses Zilebesiran and the Potential of RNAi Therapeutics for Continuous Blood Pressure Control September 17, 2026...
Alnylam Pharmaceuticals, Inc. (ALNY) Discusses Zilebesiran and the Potential of RNAi Therapeutics for Continuous Blood Pressure Control - Slideshow
2026-09-17. The following slide deck was published by Alnylam Pharmaceuticals, Inc.
Is Alnylam (ALNY) Quietly Repricing Its RNAi Risk Profile Amid Oligonucleotide Market Optimism?
Alnylam Pharmaceuticals recently presented at Wells Fargo’s 21st Annual Healthcare Conference in Boston and Morgan Stanley’s 24th Annual Global Healthcare Conference in New York, highlighting its RNA interference portfolio to investors and industry peers. These appearances coincided with a very large projected expansion of the global oligonucleotide therapeutics market to US$72.10 billions by 2035, underscoring Alnylam’s positioning as a key RNA-based medicines innovator. We’ll now examine...
Slate Medicines Names Kenneth Koblan as Chief Scientific Officer
By Karen Roman Slate Medicines Inc. said it appointed Kenneth Koblan, PhD, as its new Chief Scientific Officer, having previously served as Head of Research and Development at Vesalius Therapeutics, and at Sumitomo Pharma America as Chief Scientific Officer and Head of Development Operations. Dr. Koblan is a biopharmaceutical R&D leader with more than 30 years […] The post Slate Medicines Names Kenneth Koblan as Chief Scientific Officer appeared first on ExecEdge.
Oligonucleotide Therapeutics Market Outlook 2026-2035 - Featuring Profiles of Alnylam Pharmaceuticals, Ionis Pharmaceuticals, and Sarepta Therapeutics
Oligonucleotide Therapeutics Expand Beyond Rare Diseases as RNA Innovation, Targeted Delivery and Patient-Friendly Dosing Accelerate AdoptionDublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "Oligonucleotide Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. Global Oligonucleotide Therapeutics Market to Reach USD 72.1 Billion by 2035 at a 23.4% CAGR The global oligonucleotide therapeutics market was valu
Alnylam's Sell-Off Looks Ugly -- but Wall Street Still Sees a Much Brighter Picture
Analysts think Alnylam could rebound strongly over the next 12 months.
Alger Russell Innovation Index Updates for Third Quarter 2026
Fred Alger Management, LLC ("Alger"), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovation Index ("Index"). Following the close of trading on Friday, September 18, 2026, the Index will be rebalanced, and the following changes will be effective.
Alnylam Pharmaceuticals, Inc. (ALNY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Alnylam Pharmaceuticals, Inc. (ALNY) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 10:00 AM EDTCompany ParticipantsYvonne...
If You Invested $100 In Alnylam Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today
Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 20 years by 6.49% on an annualized basis producing an average annual return of 15.67%. Currently, Alnylam Pharmaceuticals has a market
Here’s Why Alnylam Pharmaceuticals (ALNY) Declined
American Century Investments, an investment management company, released its second-quarter 2026 investor letter for the “American Century Investments Focused Dynamic Growth Fund”. The letter can be downloaded here. U.S. stocks advanced sharply with double-digit quarterly gains largely due to robust earnings, resilient economic data, and momentum in AI-related stocks. However, there was a slight pullback […]
Alnylam Pharmaceuticals, Inc. (ALNY) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Alnylam Pharmaceuticals, Inc. (ALNY) Wells Fargo 21st Annual Healthcare Conference September 8, 2026 8:45 AM EDTCompany ParticipantsJohn Kennedy - Senior...
Hereditary Transthyretin Amyloidosis Market Insight, Epidemiology, and Market Forecast - 2036 Now Available Reveals Why a $3B Market Is Racing Toward a One-Time Curative Gene-Editing Therapy
170-Page Report Tracks Intellia and Regeneron's Nex-Z Through Phase III, Alnylam's Nucresiran Launch Plans, and the Full RNA-Silencing Competitive Landscape Reshaping hATTR TreatmentDublin, Sept. 04, 2026 (GLOBE NEWSWIRE) -- "Hereditary Transthyretin Amyloidosis - Market Insight, Epidemiology, and Market Forecast - 2036" report has been added to ResearchAndMarkets.com's offering.The report delivers an in-depth understanding of hATTR, its historical and forecasted epidemiology, and market trends
Alnylam Pharmaceuticals (NASDAQ:ALNY): Affordable Growth in Biotech
Alnylam (NASDAQ:ALNY) passes the Affordable Growth screen with strong growth, reasonable valuation, solid profitability, and healthy financials.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-19 | Greenstreet Yvonne | +107 | - | - |
| 2026-06-01 | Cravatt Benjamin | +4,393 | - | - |
| 2026-06-01 | PYOTT DAVID E I | -3,830 | - | - |
| 2026-06-01 | PYOTT DAVID E I | -17 | $302.65 | $5,145 |
| 2026-06-01 | PYOTT DAVID E I | -495 | $300.72 | $148,856 |
| 2026-06-01 | PYOTT DAVID E I | -1,222 | $299.87 | $366,441 |
| 2026-06-01 | PYOTT DAVID E I | -1,175 | $298.91 | $351,219 |
| 2026-06-01 | PYOTT DAVID E I | -921 | $297.71 | $274,191 |
| 2026-06-01 | PYOTT DAVID E I | +3,830 | - | - |
| 2026-05-20 | Sigal Charles Elliott | +1,441 | - | - |
| 2026-05-20 | Sigal Charles Elliott | +671 | - | - |
| 2026-05-20 | SCHULMAN AMY W | +1,802 | - | - |
| 2026-05-20 | SCHULMAN AMY W | +838 | - | - |
| 2026-05-20 | Reitan Colleen F | +1,441 | - | - |
| 2026-05-20 | Reitan Colleen F | +671 | - | - |
| 2026-05-20 | KELLOGG PETER N | +1,441 | - | - |
| 2026-05-20 | KELLOGG PETER N | +671 | - | - |
| 2026-05-20 | HAMBURG MARGARET A | +1,441 | - | - |
| 2026-05-20 | HAMBURG MARGARET A | +671 | - | - |
| 2026-05-20 | BRANDICOURT OLIVIER | +1,441 | - | - |
| 2026-05-20 | BRANDICOURT OLIVIER | +671 | - | - |
| 2026-05-20 | Ausiello Dennis A | +1,441 | - | - |
| 2026-05-20 | Ausiello Dennis A | +671 | - | - |
| 2026-05-20 | Arbuckle Stuart A | +1,441 | - | - |
| 2026-05-20 | Arbuckle Stuart A | +671 | - | - |
| 2026-05-20 | PYOTT DAVID E I | +1,441 | - | - |
| 2026-05-20 | PYOTT DAVID E I | +671 | - | - |
| 2026-05-13 | SCHULMAN AMY W | -11,250 | - | - |
| 2026-05-13 | SCHULMAN AMY W | +11,250 | $70.2 | $789,750 |
| 2026-04-06 | McLaughlin Melissa | -199 | $333.94 | $66,454 |
| 2026-04-06 | McLaughlin Melissa | -293 | $331.89 | $97,244 |
| 2026-04-06 | McLaughlin Melissa | -829 | $330.46 | $273,951 |
| 2026-04-06 | McLaughlin Melissa | -909 | $329.76 | $299,752 |
| 2026-04-06 | McLaughlin Melissa | -56 | $320.14 | $17,928 |
| 2026-04-02 | McLaughlin Melissa | -8 | $325.49 | $2,604 |
| 2026-04-02 | McLaughlin Melissa | -81 | $323.64 | $26,215 |
| 2026-04-02 | McLaughlin Melissa | -245 | $322.86 | $79,101 |
| 2026-04-02 | McLaughlin Melissa | -224 | $321.64 | $72,047 |
| 2026-04-02 | McLaughlin Melissa | -147 | $320.62 | $47,131 |
| 2026-04-02 | McLaughlin Melissa | -86 | $319.69 | $27,493 |
| 2026-04-02 | McLaughlin Melissa | -209 | $318.47 | $66,560 |
| 2026-04-02 | McLaughlin Melissa | -359 | $317.44 | $113,961 |
| 2026-04-02 | McLaughlin Melissa | -265 | $316.61 | $83,902 |
| 2026-03-05 | Garg Pushkal | -500 | $326.08 | $163,040 |
| 2026-03-05 | Garg Pushkal | -510 | $324.59 | $165,541 |
| 2026-03-05 | Garg Pushkal | -740 | $323.55 | $239,427 |
| 2026-03-05 | Garg Pushkal | -654 | $322.33 | $210,804 |
| 2026-03-05 | Fitzgerald Kevin Joseph | -153 | $326.24 | $49,915 |
| 2026-03-05 | Fitzgerald Kevin Joseph | -148 | $324.6 | $48,041 |
| 2026-03-05 | Fitzgerald Kevin Joseph | -233 | $323.25 | $75,317 |
| 2026-03-05 | Fitzgerald Kevin Joseph | -124 | $321.81 | $39,904 |
| 2026-03-04 | Garg Pushkal | -208 | $325.67 | $67,739 |
| 2026-03-04 | Garg Pushkal | -272 | $324.88 | $88,367 |
| 2026-03-04 | Garg Pushkal | -767 | $323.84 | $248,385 |
| 2026-03-04 | Garg Pushkal | -350 | $323.01 | $113,054 |
| 2026-03-04 | Garg Pushkal | -289 | $321.82 | $93,006 |
| 2026-03-04 | Garg Pushkal | -215 | $320.81 | $68,974 |
| 2026-03-04 | Garg Pushkal | -102 | $320.01 | $32,641 |
| 2026-03-04 | Garg Pushkal | -106 | $319.03 | $33,817 |
| 2026-03-04 | Greenstreet Yvonne | -265 | $325.67 | $86,303 |
| 2026-03-04 | Greenstreet Yvonne | -345 | $324.88 | $112,084 |
| 2026-03-04 | Greenstreet Yvonne | -973 | $323.84 | $315,096 |
| 2026-03-04 | Greenstreet Yvonne | -444 | $323.01 | $143,416 |
| 2026-03-04 | Greenstreet Yvonne | -368 | $321.82 | $118,430 |
| 2026-03-04 | Greenstreet Yvonne | -274 | $320.81 | $87,902 |
| 2026-03-04 | Greenstreet Yvonne | -129 | $320.01 | $41,281 |
| 2026-03-04 | Greenstreet Yvonne | -135 | $319.03 | $43,069 |
| 2026-03-04 | Poulton Jeffrey V. | -223 | $325.67 | $72,624 |
| 2026-03-04 | Poulton Jeffrey V. | -291 | $324.88 | $94,540 |
| 2026-03-04 | Poulton Jeffrey V. | -818 | $323.84 | $264,901 |
| 2026-03-04 | Poulton Jeffrey V. | -374 | $323.01 | $120,806 |
| 2026-03-04 | Poulton Jeffrey V. | -309 | $321.82 | $99,442 |
| 2026-03-04 | Poulton Jeffrey V. | -230 | $320.81 | $73,786 |
| 2026-03-04 | Poulton Jeffrey V. | -109 | $320.01 | $34,881 |
| 2026-03-04 | Poulton Jeffrey V. | -114 | $319.03 | $36,369 |
| 2026-03-04 | Tanguler Tolga | -208 | $325.67 | $67,739 |
| 2026-03-04 | Tanguler Tolga | -272 | $324.88 | $88,367 |
| 2026-03-04 | Tanguler Tolga | -767 | $323.84 | $248,385 |
| 2026-03-04 | Tanguler Tolga | -350 | $323.01 | $113,054 |
| 2026-03-04 | Tanguler Tolga | -289 | $321.82 | $93,006 |
| 2026-03-04 | Tanguler Tolga | -215 | $320.81 | $68,974 |
| 2026-03-04 | Tanguler Tolga | -102 | $320.01 | $32,641 |
| 2026-03-04 | Tanguler Tolga | -106 | $319.03 | $33,817 |
| 2026-03-04 | Fitzgerald Kevin Joseph | -57 | $325.67 | $18,563 |
| 2026-03-04 | Fitzgerald Kevin Joseph | -75 | $324.88 | $24,366 |
| 2026-03-04 | Fitzgerald Kevin Joseph | -210 | $323.84 | $68,006 |
| 2026-03-04 | Fitzgerald Kevin Joseph | -96 | $323.01 | $31,009 |
| 2026-03-04 | Fitzgerald Kevin Joseph | -79 | $321.82 | $25,424 |
| 2026-03-04 | Fitzgerald Kevin Joseph | -59 | $320.81 | $18,928 |
| 2026-03-04 | Fitzgerald Kevin Joseph | -28 | $320.01 | $8,960 |
| 2026-03-04 | Fitzgerald Kevin Joseph | -29 | $319.03 | $9,252 |
| 2026-03-03 | Garg Pushkal | -463 | $321.5 | $148,855 |
| 2026-03-03 | Garg Pushkal | -640 | $320.48 | $205,107 |
| 2026-03-03 | Garg Pushkal | -317 | $319.06 | $101,142 |
| 2026-03-03 | Garg Pushkal | -355 | $316.74 | $112,443 |
| 2026-03-03 | Fitzgerald Kevin Joseph | -359 | $321.58 | $115,447 |
| 2026-03-03 | Fitzgerald Kevin Joseph | -722 | $320.51 | $231,408 |
| 2026-03-03 | Fitzgerald Kevin Joseph | -282 | $318.62 | $89,851 |
| 2026-03-03 | Fitzgerald Kevin Joseph | -289 | $316.55 | $91,483 |
| 2026-03-02 | Poulton Jeffrey V. | +10,480 | - | - |
| 2026-03-02 | Poulton Jeffrey V. | -53 | $332.64 | $17,630 |
| 2026-03-02 | Poulton Jeffrey V. | -129 | $331.93 | $42,819 |
| 2026-03-02 | Poulton Jeffrey V. | -112 | $330.85 | $37,055 |
| 2026-03-02 | Poulton Jeffrey V. | -234 | $329.71 | $77,152 |
| 2026-03-02 | Poulton Jeffrey V. | -138 | $328.71 | $45,362 |
| 2026-03-02 | Poulton Jeffrey V. | -454 | $327.67 | $148,762 |
| 2026-03-02 | Poulton Jeffrey V. | -541 | $326.81 | $176,804 |
| 2026-03-02 | Poulton Jeffrey V. | -356 | $325.63 | $115,924 |
| 2026-03-02 | Poulton Jeffrey V. | -124 | $324.65 | $40,257 |
| 2026-03-02 | Poulton Jeffrey V. | -65 | $323.62 | $21,035 |
| 2026-03-02 | Poulton Jeffrey V. | +4,769 | - | - |
| 2026-03-02 | Garg Pushkal | +10,480 | - | - |
| 2026-03-02 | Garg Pushkal | -42 | $332.64 | $13,971 |
| 2026-03-02 | Garg Pushkal | -101 | $331.93 | $33,525 |
| 2026-03-02 | Garg Pushkal | -87 | $330.85 | $28,784 |
| 2026-03-02 | Garg Pushkal | -182 | $329.71 | $60,007 |
| 2026-03-02 | Garg Pushkal | -107 | $328.71 | $35,172 |
| 2026-03-02 | Garg Pushkal | -353 | $327.67 | $115,668 |
| 2026-03-02 | Garg Pushkal | -421 | $326.81 | $137,587 |
| 2026-03-02 | Garg Pushkal | -277 | $325.63 | $90,200 |
| 2026-03-02 | Garg Pushkal | -97 | $324.65 | $31,491 |
| 2026-03-02 | Garg Pushkal | -50 | $323.62 | $16,181 |
| 2026-03-02 | Garg Pushkal | +4,769 | - | - |
| 2026-03-02 | Fitzgerald Kevin Joseph | +8,105 | - | - |
| 2026-03-02 | Fitzgerald Kevin Joseph | -37 | $332.64 | $12,308 |
| 2026-03-02 | Fitzgerald Kevin Joseph | -94 | $331.93 | $31,201 |
| 2026-03-02 | Fitzgerald Kevin Joseph | -81 | $330.85 | $26,799 |
| 2026-03-02 | Fitzgerald Kevin Joseph | -170 | $329.71 | $56,051 |
| 2026-03-02 | Fitzgerald Kevin Joseph | -100 | $328.71 | $32,871 |
| 2026-03-02 | Fitzgerald Kevin Joseph | -329 | $327.67 | $107,803 |
| 2026-03-02 | Fitzgerald Kevin Joseph | -392 | $326.81 | $128,110 |
| 2026-03-02 | Fitzgerald Kevin Joseph | -258 | $325.63 | $84,013 |
| 2026-03-02 | Fitzgerald Kevin Joseph | -90 | $324.65 | $29,218 |
| 2026-03-02 | Fitzgerald Kevin Joseph | -47 | $323.62 | $15,210 |
| 2026-03-02 | Fitzgerald Kevin Joseph | +3,688 | - | - |
| 2026-03-02 | Tanguler Tolga | +10,480 | - | - |
| 2026-03-02 | Tanguler Tolga | -37 | $332.64 | $12,308 |
| 2026-03-02 | Tanguler Tolga | -94 | $331.93 | $31,201 |
| 2026-03-02 | Tanguler Tolga | -81 | $330.85 | $26,799 |
| 2026-03-02 | Tanguler Tolga | -170 | $329.71 | $56,051 |
| 2026-03-02 | Tanguler Tolga | -100 | $328.71 | $32,871 |
| 2026-03-02 | Tanguler Tolga | -329 | $327.67 | $107,803 |
| 2026-03-02 | Tanguler Tolga | -392 | $326.81 | $128,110 |
| 2026-03-02 | Tanguler Tolga | -258 | $325.63 | $84,013 |
| 2026-03-02 | Tanguler Tolga | -90 | $324.65 | $29,218 |
| 2026-03-02 | Tanguler Tolga | -47 | $323.62 | $15,210 |
| 2026-03-02 | Tanguler Tolga | +4,769 | - | - |
| 2026-03-02 | SUPRAN BRYAN | +3,381 | - | - |
| 2026-03-02 | SUPRAN BRYAN | +1,539 | - | - |
| 2026-03-02 | Greenstreet Yvonne | +110,746 | - | - |
| 2026-03-02 | Greenstreet Yvonne | +30,425 | - | - |
| 2026-03-02 | Greenstreet Yvonne | -160 | $332.64 | $53,222 |
| 2026-03-02 | Greenstreet Yvonne | -399 | $331.93 | $132,440 |
| 2026-03-02 | Greenstreet Yvonne | -346 | $330.85 | $114,474 |
| 2026-03-02 | Greenstreet Yvonne | -722 | $329.71 | $238,051 |
| 2026-03-02 | Greenstreet Yvonne | -424 | $328.71 | $139,373 |
| 2026-03-02 | Greenstreet Yvonne | -1,399 | $327.67 | $458,410 |
| 2026-03-02 | Greenstreet Yvonne | -1,669 | $326.81 | $545,446 |
| 2026-03-02 | Greenstreet Yvonne | -1,098 | $325.63 | $357,542 |
| 2026-03-02 | Greenstreet Yvonne | -382 | $324.65 | $124,016 |
| 2026-03-02 | Greenstreet Yvonne | -200 | $323.62 | $64,724 |
| 2026-03-02 | Greenstreet Yvonne | +13,844 | - | - |
| 2026-02-27 | Greenstreet Yvonne | -5,921 | - | - |
| 2026-02-27 | Greenstreet Yvonne | +5,921 | - | - |
| 2026-02-27 | Poulton Jeffrey V. | -1,908 | - | - |
| 2026-02-27 | Poulton Jeffrey V. | +1,908 | - | - |
| 2026-02-27 | Tanguler Tolga | -1,666 | - | - |
| 2026-02-27 | Tanguler Tolga | +1,666 | - | - |
| 2026-02-27 | Garg Pushkal | -1,908 | - | - |
| 2026-02-27 | Garg Pushkal | -140 | $334.39 | $46,815 |
| 2026-02-27 | Garg Pushkal | -942 | $332.48 | $313,196 |
| 2026-02-27 | Garg Pushkal | -1,159 | $331.49 | $384,197 |
| 2026-02-27 | Garg Pushkal | -2,259 | $330.73 | $747,119 |
| 2026-02-27 | Garg Pushkal | -127 | $328.92 | $41,773 |
| 2026-02-27 | Garg Pushkal | +1,908 | - | - |
| 2026-02-23 | Fitzgerald Kevin Joseph | +158 | - | - |
| 2026-02-17 | Fitzgerald Kevin Joseph | -2,041 | $331.9606 | $677,532 |
| 2026-02-13 | Garg Pushkal | -2,242 | $310.0808 | $695,201 |
| 2026-02-13 | Greenstreet Yvonne | -6,958 | $310.0808 | $2,157,542 |
| 2026-02-13 | Tanguler Tolga | -1,959 | $310.0808 | $607,448 |
| 2026-02-13 | Fitzgerald Kevin Joseph | -1,959 | $310.0808 | $607,448 |
| 2026-02-13 | Poulton Jeffrey V. | -2,242 | $310.0808 | $695,201 |
| 2026-02-12 | Garg Pushkal | +4,579 | - | - |
| 2026-02-12 | Greenstreet Yvonne | +14,209 | - | - |
| 2026-02-12 | Tanguler Tolga | +4,000 | - | - |
| 2026-02-12 | Fitzgerald Kevin Joseph | +4,000 | - | - |
| 2026-02-12 | Poulton Jeffrey V. | +4,579 | - | - |
| 2026-01-13 | Fitzgerald Kevin Joseph | -122 | $374.33 | $45,668 |
| 2026-01-13 | Fitzgerald Kevin Joseph | -280 | $372.93 | $104,420 |
| 2026-01-13 | Fitzgerald Kevin Joseph | -485 | $371.24 | $180,051 |
| 2026-01-13 | Fitzgerald Kevin Joseph | -644 | $370 | $238,280 |
| 2026-01-13 | Fitzgerald Kevin Joseph | -562 | $368.76 | $207,243 |
| 2026-01-13 | Fitzgerald Kevin Joseph | -197 | $367.52 | $72,401 |
| 2026-01-12 | Garg Pushkal | -15 | $377.82 | $5,667 |
| 2026-01-12 | Garg Pushkal | -19 | $375.65 | $7,137 |
| 2026-01-12 | Garg Pushkal | -14 | $374.44 | $5,242 |
| 2026-01-12 | Garg Pushkal | -3 | $372.46 | $1,117 |
| 2026-01-12 | Garg Pushkal | -18 | $370.87 | $6,676 |
| 2026-01-12 | Garg Pushkal | -40 | $369.48 | $14,779 |
| 2026-01-12 | Garg Pushkal | -92 | $368.62 | $33,913 |
| 2026-01-12 | Garg Pushkal | -41 | $367.4 | $15,063 |
| 2026-01-12 | Garg Pushkal | -50 | $366.41 | $18,321 |
| 2026-01-12 | Garg Pushkal | -220 | $365.56 | $80,423 |
| 2026-01-12 | Garg Pushkal | -199 | $364.83 | $72,601 |
| 2026-01-12 | Garg Pushkal | -47 | $363.55 | $17,087 |
| 2026-01-12 | Garg Pushkal | -73 | $362.38 | $26,454 |
| 2026-01-12 | Garg Pushkal | -98 | $361.45 | $35,422 |
| 2026-01-12 | Garg Pushkal | -155 | $360.22 | $55,834 |
| 2026-01-12 | Garg Pushkal | -85 | $359.14 | $30,527 |
| 2026-01-12 | Garg Pushkal | -123 | $358.18 | $44,056 |
| 2026-01-12 | Garg Pushkal | -96 | $357.17 | $34,288 |
| 2026-01-12 | Garg Pushkal | -41 | $356.09 | $14,600 |
| 2026-01-12 | Garg Pushkal | -42 | $355.16 | $14,917 |
| 2026-01-12 | Garg Pushkal | -39 | $353.95 | $13,804 |
| 2026-01-12 | Greenstreet Yvonne | -94 | $377.82 | $35,515 |
| 2026-01-12 | Greenstreet Yvonne | -118 | $375.65 | $44,327 |
| 2026-01-12 | Greenstreet Yvonne | -88 | $374.44 | $32,951 |
| 2026-01-12 | Greenstreet Yvonne | -21 | $372.46 | $7,822 |
| 2026-01-12 | Greenstreet Yvonne | -118 | $370.87 | $43,763 |
| 2026-01-12 | Greenstreet Yvonne | -253 | $369.48 | $93,478 |
| 2026-01-12 | Greenstreet Yvonne | -584 | $368.62 | $215,274 |
| 2026-01-12 | Greenstreet Yvonne | -261 | $367.4 | $95,891 |
| 2026-01-12 | Greenstreet Yvonne | -316 | $366.41 | $115,786 |
| 2026-01-12 | Greenstreet Yvonne | -1,395 | $365.56 | $509,956 |
| 2026-01-12 | Greenstreet Yvonne | -1,259 | $364.83 | $459,321 |
| 2026-01-12 | Greenstreet Yvonne | -301 | $363.55 | $109,429 |
| 2026-01-12 | Greenstreet Yvonne | -464 | $362.38 | $168,144 |
| 2026-01-12 | Greenstreet Yvonne | -624 | $361.45 | $225,545 |
| 2026-01-12 | Greenstreet Yvonne | -980 | $360.22 | $353,016 |
| 2026-01-12 | Greenstreet Yvonne | -537 | $359.14 | $192,858 |
| 2026-01-12 | Greenstreet Yvonne | -778 | $358.18 | $278,664 |
| 2026-01-12 | Greenstreet Yvonne | -607 | $357.17 | $216,802 |
| 2026-01-12 | Greenstreet Yvonne | -263 | $356.09 | $93,652 |
| 2026-01-12 | Greenstreet Yvonne | -269 | $355.16 | $95,538 |
| 2026-01-12 | Greenstreet Yvonne | -247 | $353.95 | $87,426 |
| 2026-01-12 | Poulton Jeffrey V. | -27 | $377.82 | $10,201 |
| 2026-01-12 | Poulton Jeffrey V. | -34 | $375.65 | $12,772 |
| 2026-01-12 | Poulton Jeffrey V. | -25 | $374.44 | $9,361 |
| 2026-01-12 | Poulton Jeffrey V. | -6 | $372.46 | $2,235 |
| 2026-01-12 | Poulton Jeffrey V. | -36 | $370.87 | $13,351 |
| 2026-01-12 | Poulton Jeffrey V. | -73 | $369.48 | $26,972 |
| 2026-01-12 | Poulton Jeffrey V. | -170 | $368.62 | $62,665 |
| 2026-01-12 | Poulton Jeffrey V. | -76 | $367.4 | $27,922 |
| 2026-01-12 | Poulton Jeffrey V. | -92 | $366.41 | $33,710 |
| 2026-01-12 | Poulton Jeffrey V. | -405 | $365.56 | $148,052 |
| 2026-01-12 | Poulton Jeffrey V. | -365 | $364.83 | $133,163 |
| 2026-01-12 | Poulton Jeffrey V. | -87 | $363.55 | $31,629 |
| 2026-01-12 | Poulton Jeffrey V. | -135 | $362.38 | $48,921 |
| 2026-01-12 | Poulton Jeffrey V. | -181 | $361.45 | $65,422 |
| 2026-01-12 | Poulton Jeffrey V. | -284 | $360.22 | $102,302 |
| 2026-01-12 | Poulton Jeffrey V. | -156 | $359.14 | $56,026 |
| 2026-01-12 | Poulton Jeffrey V. | -226 | $358.18 | $80,949 |
| 2026-01-12 | Poulton Jeffrey V. | -176 | $357.17 | $62,862 |
| 2026-01-12 | Poulton Jeffrey V. | -76 | $356.09 | $27,063 |
| 2026-01-12 | Poulton Jeffrey V. | -78 | $355.16 | $27,702 |
| 2026-01-12 | Poulton Jeffrey V. | -72 | $353.95 | $25,484 |
| 2026-01-12 | Tanguler Tolga | -15 | $377.82 | $5,667 |
| 2026-01-12 | Tanguler Tolga | -19 | $375.65 | $7,137 |
| 2026-01-12 | Tanguler Tolga | -14 | $374.44 | $5,242 |
| 2026-01-12 | Tanguler Tolga | -2 | $372.46 | $745 |
| 2026-01-12 | Tanguler Tolga | -19 | $370.87 | $7,047 |
| 2026-01-12 | Tanguler Tolga | -40 | $369.48 | $14,779 |
| 2026-01-12 | Tanguler Tolga | -92 | $368.62 | $33,913 |
| 2026-01-12 | Tanguler Tolga | -41 | $367.4 | $15,063 |
| 2026-01-12 | Tanguler Tolga | -50 | $366.41 | $18,321 |
| 2026-01-12 | Tanguler Tolga | -220 | $365.56 | $80,423 |
| 2026-01-12 | Tanguler Tolga | -199 | $364.83 | $72,601 |
| 2026-01-12 | Tanguler Tolga | -47 | $363.55 | $17,087 |
| 2026-01-12 | Tanguler Tolga | -73 | $362.38 | $26,454 |
| 2026-01-12 | Tanguler Tolga | -98 | $361.45 | $35,422 |
| 2026-01-12 | Tanguler Tolga | -155 | $360.22 | $55,834 |
| 2026-01-12 | Tanguler Tolga | -85 | $359.14 | $30,527 |
| 2026-01-12 | Tanguler Tolga | -123 | $358.18 | $44,056 |
| 2026-01-12 | Tanguler Tolga | -96 | $357.17 | $34,288 |
| 2026-01-12 | Tanguler Tolga | -41 | $356.09 | $14,600 |
| 2026-01-12 | Tanguler Tolga | -42 | $355.16 | $14,917 |
| 2026-01-12 | Tanguler Tolga | -39 | $353.95 | $13,804 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -15 | $377.82 | $5,667 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -19 | $375.65 | $7,137 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -14 | $374.44 | $5,242 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -2 | $372.46 | $745 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -19 | $370.87 | $7,047 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -40 | $369.48 | $14,779 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -92 | $368.62 | $33,913 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -41 | $367.4 | $15,063 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -50 | $366.41 | $18,321 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -220 | $365.56 | $80,423 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -199 | $364.83 | $72,601 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -47 | $363.55 | $17,087 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -73 | $362.38 | $26,454 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -98 | $361.45 | $35,422 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -155 | $360.22 | $55,834 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -85 | $359.14 | $30,527 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -123 | $358.18 | $44,056 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -96 | $357.17 | $34,288 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -41 | $356.09 | $14,600 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -42 | $355.16 | $14,917 |
| 2026-01-12 | Fitzgerald Kevin Joseph | -39 | $353.95 | $13,804 |
| 2026-01-11 | Garg Pushkal | +3,800 | - | - |
| 2026-01-11 | Greenstreet Yvonne | +19,003 | - | - |
| 2026-01-11 | Poulton Jeffrey V. | +6,193 | - | - |
| 2026-01-11 | Tanguler Tolga | +3,800 | - | - |
| 2026-01-11 | Fitzgerald Kevin Joseph | +3,800 | - | - |
| 2026-01-05 | Arbuckle Stuart A | +3,279 | - | - |
| 2025-11-26 | Greenstreet Yvonne | -659 | - | - |
| 2025-11-26 | Greenstreet Yvonne | -839 | - | - |
| 2025-11-26 | Greenstreet Yvonne | -847 | - | - |
| 2025-11-26 | Greenstreet Yvonne | -2,352 | - | - |
| 2025-11-26 | Greenstreet Yvonne | -1,121 | $445.12 | $498,980 |
| 2025-11-26 | Greenstreet Yvonne | +659 | $151.59 | $99,898 |
| 2025-11-26 | Greenstreet Yvonne | +847 | $118.05 | $99,988 |
| 2025-11-26 | Greenstreet Yvonne | +2,352 | $85 | $199,920 |
| 2025-11-26 | Greenstreet Yvonne | +839 | $119.13 | $99,950 |
| 2025-11-17 | Fitzgerald Kevin Joseph | -8,161 | - | - |
| 2025-11-17 | Fitzgerald Kevin Joseph | -295 | $463.08 | $136,609 |
| 2025-11-17 | Fitzgerald Kevin Joseph | -323 | $461.96 | $149,213 |
| 2025-11-17 | Fitzgerald Kevin Joseph | -707 | $460.84 | $325,814 |
| 2025-11-17 | Fitzgerald Kevin Joseph | -622 | $459.89 | $286,052 |
| 2025-11-17 | Fitzgerald Kevin Joseph | -794 | $458.41 | $363,978 |
| 2025-11-17 | Fitzgerald Kevin Joseph | -262 | $457.39 | $119,836 |
| 2025-11-17 | Fitzgerald Kevin Joseph | -364 | $456.25 | $166,075 |
| 2025-11-17 | Fitzgerald Kevin Joseph | -368 | $455.24 | $167,528 |
| 2025-11-17 | Fitzgerald Kevin Joseph | -129 | $451.51 | $58,245 |
| 2025-11-17 | Fitzgerald Kevin Joseph | -96 | $450.09 | $43,209 |
| 2025-11-17 | Fitzgerald Kevin Joseph | -8,168 | $449 | $3,667,432 |
| 2025-11-17 | Fitzgerald Kevin Joseph | +8,161 | $119.13 | $972,220 |
| 2025-11-13 | Greenstreet Yvonne | -10,000 | - | - |
| 2025-11-13 | Greenstreet Yvonne | -261 | $456.03 | $119,024 |
| 2025-11-13 | Greenstreet Yvonne | -195 | $454.69 | $88,665 |
| 2025-11-13 | Greenstreet Yvonne | -881 | $453.99 | $399,965 |
| 2025-11-13 | Greenstreet Yvonne | -1,599 | $452.85 | $724,107 |
| 2025-11-13 | Greenstreet Yvonne | -1,702 | $451.94 | $769,202 |
| 2025-11-13 | Greenstreet Yvonne | -2,218 | $450.69 | $999,630 |
| 2025-11-13 | Greenstreet Yvonne | -1,477 | $450.02 | $664,680 |
| 2025-11-13 | Greenstreet Yvonne | -1,013 | $448.76 | $454,594 |
| 2025-11-13 | Greenstreet Yvonne | -654 | $447.73 | $292,815 |
| 2025-11-13 | Greenstreet Yvonne | +10,000 | $119.13 | $1,191,300 |
| 2025-11-12 | Greenstreet Yvonne | -15,000 | - | - |
| 2025-11-12 | Greenstreet Yvonne | -650 | - | - |
| 2025-11-12 | Greenstreet Yvonne | -430 | $458.42 | $197,121 |
| 2025-11-12 | Greenstreet Yvonne | -604 | $457.71 | $276,457 |
| 2025-11-12 | Greenstreet Yvonne | -2,420 | $456.64 | $1,105,069 |
| 2025-11-12 | Greenstreet Yvonne | -3,406 | $455.56 | $1,551,637 |
| 2025-11-12 | Greenstreet Yvonne | -1,960 | $454.84 | $891,486 |
| 2025-11-12 | Greenstreet Yvonne | -1,069 | $453.52 | $484,813 |
| 2025-11-12 | Greenstreet Yvonne | -1,210 | $452.43 | $547,440 |
| 2025-11-12 | Greenstreet Yvonne | -1,255 | $451.16 | $566,206 |
| 2025-11-12 | Greenstreet Yvonne | -453 | $450.17 | $203,927 |
| 2025-11-12 | Greenstreet Yvonne | -2,132 | $449.15 | $957,588 |
| 2025-11-12 | Greenstreet Yvonne | -711 | $448.07 | $318,578 |
| 2025-11-12 | Greenstreet Yvonne | +15,000 | $119.13 | $1,786,950 |
| 2025-11-12 | Greenstreet Yvonne | +650 | $42.22 | $27,443 |
| 2025-10-03 | Garg Pushkal | -215 | $454.37 | $97,690 |
| 2025-10-03 | Garg Pushkal | -417 | $453.51 | $189,114 |
| 2025-10-03 | Garg Pushkal | -898 | $451.76 | $405,680 |
| 2025-10-03 | Garg Pushkal | -810 | $450.63 | $365,010 |
| 2025-10-03 | Garg Pushkal | -682 | $449.99 | $306,893 |